Florealis is a leading brand dedicated to innovation, quality, and creating value for its customers, employees, shareholders, and society. Their mission is to improve people's health through the excellence of science and nature. Florealis offers a unique range of registered products that effectively treat common diseases using active natural ingredients.

Their product line includes herbal medicines for intimate health and dermatology. They specialize in addressing conditions like anxiety, sleep disorders, migraines, and arthritic pain. These diseases affect millions globally but are currently underserved by the healthcare community.

Florealis has rapidly expanded its sales channels, with their products currently available in 1200 pharmacies in Iceland and Sweden. All their products have undergone approved registration and are certified by medical authorities in the Nordic countries. The company's values of accountability, passion, courage, and collaboration are the foundation for their strategy and success.

Founded in 2013 by Kolbrún Hrafnkelsdóttir and experienced professionals from the pharmaceutical industry, Florealis has a management team consisting of individuals with diverse backgrounds and a shared passion for increasing professionalism and quality in the herbal medicine industry. The board of directors, led by chairman Guðbjörg Edda Eggertsdóttir, brings industry expertise to guide the brand's growth. The team at Florealis combines their extensive experience in the pharmaceutical and medical industries to develop and market high-quality products.

With their commitment to excellence, innovation, and improving people's health, Florealis is a trusted brand in the herbal medicine industry